ReviewMolecular neurobiology2026
The Diet-Multiple Sclerosis Connection: Oxidative Stress and Emerging Mechanisms.
Review in Molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Multiple sclerosis (MS) is an autoimmune neuroinflammatory disease resulting in myelin degeneration and progressive disability. Oxidative stress plays a crucial role in MS pathogenesis and progression. Nuclear factor erythroid 2-related factor 2 (Nrf2) is a master regulator of the antioxidant mechanisms and its upregulation is associated with beneficial effects in MS. Among the environmental factors influencing MS onset and progression, diet represents a promising non-pharmacological strategy to modulate Nrf2, potentially improving MS outcomes. Indeed, several natural compounds present in Mediterranean, ketogenic and Paleolithic diets can enhance Nrf2 activity, and exert beneficial effects in preclinical models of MS. In this review, we summarize the key role of oxidative stress in MS and highlight how dietary regimens and Nrf2-modulating natural compounds might have therapeutic potential for MS patients. Additionally, we discuss emerging and still poorly explored mechanisms beyond classical Nrf2 activation, including epigenetic regulation and the stability of DNA/RNA secondary structures known as G-quadruplexes, which are involved in gene expression regulation and may represent novel nutrition-based therapeutic targets. However, while Nrf2 modulation by diet is supported by preclinical and limited clinical evidence, targeting G-quadruplexes as a strategy to counteract oxidative stress in MS remains largely speculative and requires further investigation. Notably, epigenetic mechanisms and G-quadruplexes may represent innovative targets of Nrf2-boosting dietary natural compounds for the development of supplemental therapeutic strategies for MS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.